Inventor · disambiguated record
Sean Doyle
Also filed as: DOYLE SEAN · DOYLE SEAN E
5 granted patents·1 pending application·77 citations·filing 2003–2022
78Inventor score
Top patents by PatentIndex Score
6 records- 0196US7351689B2Use of IL-28 and IL-29 to treat cancer and autoimmune disordersZYMOGENETICS INC·Filed 2005·Granted Apr 1, 2008·68 cites·6 claims
- 0290US12227575B2Combination of TIM-4 antagonist and PD-1 antagonist and methods of useBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Feb 18, 2025·1 cites·15 claims
- 0386US7786075B2Use of IL-28 and IL-29 to treat cancer and autoimmune disordersZYMOGENETICS LLC·Filed 2008·Granted Aug 31, 2010·7 cites·12 claims
- 0477US11306143B2Combination of TIM-4 antagonist and PD-1 antagonist and methods of useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 19, 2022·1 cites·13 claims
- 0554US8361954B2Use of IL-28 and IL-29 to treat cancer and autoimmune disordersZYMOGENETICS INC·Filed 2010·Granted Jan 29, 2013·0 cites·12 claims
- 0642US2006057104A1Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responsesUNIV CALIFORNIA OFFICE OF THE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean Doyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →